Skip to contentClarengateINTELLIGENCE
Companies/07650751

Onca Xt Limited

Company profile

DissolvedUnited Kingdom
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2016-12-31

IXBRL · 48 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2016-01-01 to 2016-12-31
Extraction status
Legacy / not assessed
Numeric facts
16
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0042_07650751_20161231
Source archive
Accounts_Monthly_Data-May2017.zip

Accounts to 2015-12-31

IXBRL · 50 source facts · 15 selected values

Not assessed
legacy record
Reporting period
2015-01-01 to 2015-12-31
Extraction status
Legacy / not assessed
Numeric facts
25
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0027_07650751_20151231
Source archive
Accounts_Monthly_Data-February2016.zip

Accounts to 2011-12-31

IXBRL · 22 source facts · 3 selected values

Not assessed
legacy record
Reporting period
2011-05-27 to 2011-12-31
Extraction status
Legacy / not assessed
Numeric facts
6
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-main-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_9975_07650751_20111231
Source archive
Accounts_Monthly_Data-February2012.zip

Registered details

07650751
Status
Dissolved
Type
Unknown
Incorporated
—
Jurisdiction
—
Registered office
—

Classification

0 SIC codes

No SIC classification available.

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

1 matched grants
Feasibility study on new test for Prostate CancerLead
Innovate UK · Feasibility Studies · 2015-04-01 – 2016-03-31 · with 1 other participant
£72,105
awarded
Oncascan Limitedlead£72,105